Skip to content
Home/Companies/Biotech/Vivalyx
Vivalyx

Vivalyx

Biotech·Germany·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Vivalyx?

Vivalyx is currently owned by S-UBG AG Aachen Krefeld Mönchengladbach through TechVision Fonds I (2020 vintage), since 2024.

Hand-verified · updated 2026-08-10

S-UBG AG Aachen Krefeld Mönchengladbach
Investor
S-UBG AG Aachen Krefeld Mönchengladbach
TechVision Fonds I · 2020 · VC

Key facts

HQGermany
SectorBiotech
StatusActive
Websitevivalyx.com

More from TechVision Fonds I

Other portfolio companies in the same fund.

Black Semiconductor
Active
Deep TechGermany· 2024
Eeden
Active
ClimateTechGermany· 2022
CUREosity
Active
HealthTechGermany· 2021

More S-UBG AG Aachen Krefeld Mönchengladbach portfolio companies

From the same investor, across funds.

LD Didactic
LD Didactic
Exited 2026
EdTechGermany· 2023
to
KERPEN DATACOM
Kerpen Datacom
Active
TelecomGermany· 2021
Palmer Hargreaves
Active
Business ServicesGermany· 2020
MOQO
MOQO
Active
MobilityGermany· 2019
Taxy.io
Taxy.io
Exited 2025
FintechGermany· 2019
to
AMEPA
Amepa
Exited 2024
IndustrialsGermany· 2018
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Vivalyx

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Vivalyx.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue